Some useful links:
Cancer Research Horizons is CRUK’s innovation engine built to complement it’s network of researchers. They take innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
The report from Deloitte showing the cost of developing new drugs – an expense that now exceeds $2 billion per therapy on average.
FDA Commissioner Rob Califf says drug prices are too high.
